EMA — authorised 30 June 2014
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
EMA authorised Mekinist on 30 June 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 30 June 2014.
NOVARTIS EUROPHARM LIMITED holds the EU marketing authorisation.